Novo investors call for dealmaking and new drugs
Direct Source Verification:
This story is aggregated from Financial Times (ft.com). Full reporting rights and copyright belong to the primary publisher.
Ozempic maker is under pressure to diversify as it prepares to face shareholders on Monday
For complete coverage, context, and related multimedia, visit the original reporting by Financial Times via the source link below.
Original Source
https://www.ft.com/content/e560fd8c-5cc2-4743-90eb-eab71b899ce6?syn-25a6b1a6=1
